strategic alternatives

23andMe is exploring strategic alternatives, looking to raise capital

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year. 23andMe said it will "need additional liquidity" to fund its operations, and it is looking to raise additional capital.

Business Insider · 1d

Veradigm ends exploration of strategic alternatives without deal

Veradigm (MDRX) announced that its board of directors completed its previously announced review of strategic alternatives. “Throughout the

Business Wire · 1d

Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “

Seeking Alpha on MSN · 1d

Veradigm ends strategic review after no firm bids

Veradigm (OTC:MDRX) said that it's ending a strategic review after it received no firm proposals in its process. The electronic medical records firm disclosed that five bidders made preliminary, non-biding indications of interest,

Business Insider · 3d

23andMe announces exploration of strategic alternatives

The Special Committee of the board of 23andMe Holding Co. announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a poss

Crain's Chicago Business1d

Veradigm fails to find a buyer, moves to operational review

The health tech company formerly known as Allscripts, still reeling from failing to fix its financial reports, will have to ...

Sage rejects Biogen’s buyout offer, but says it's open to deals

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Zacks.com on MSN12d

NGVT to Evaluate Strategic Alternatives for Industrial Specialties

Ingevity Corporation NGVT recently announced plans to explore strategic alternatives for its Performance Chemicals Industrial ...

FiercePharma5d

No deal: Sage rejects Biogen's buyout offer, scouts for strategic alternatives

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...

Hosted on MSN18d

S&W Seed rises after starting review of strategic alternatives

S &W Seed (NASDAQ:SANW) +4.8% post-market Monday after saying its board has launched a process to explore and evaluate various strategic alternatives, including a sale of the company, a merger ...

Genetic test maker 23andMe eyes strategic alternatives, including a sale

Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results